CHONC study materials
CHONC study resources

CHONC common mistakes

CHONC · Understand the traps and how to avoid them.

Mistake 1

Staging an oral cavity or laryngeal tumor using the imaging report's measurements without verifying whether the recorded T category is based on the imaging size or the resected specimen size, and mixing the two in one stage assignment.

Candidates memorize size cutoffs per subsite but forget that pathologic T and clinical T use different data sources, and imaging measurements often exceed specimen measurements due to fixation shrinkage and inclusion of surrounding tissue.

What to do instead

Before assigning any T category, state explicitly whether the stage is clinical or pathologic and use only that data source; when both are available, record cTNM and pTNM separately and never substitute one measurement into the other's category.

Mistake 2

Treating all level I-III neck dissections as equivalent and failing to distinguish a selective neck dissection (SND) from a modified radical neck dissection (MRND) when describing surgical extent or answering questions about nodal yield expectations.

The nomenclature is superficially similar and candidates conflate 'preserving structures' with 'preserving levels'; MRND preserves the spinal accessory nerve, IJV, and SCM but removes levels I-V.

What to do instead

Build a levels-removed versus structures-preserved grid for radical, MRND, and each SND subtype, and answer by naming the levels removed first, then the structures preserved.

Mistake 3

Recommending postoperative radiation alone for a patient with a positive margin or extranodal extension instead of adding concurrent cisplatin.

Candidates correctly recall that these are high-risk features warranting postoperative RT but stop at the radiation decision and omit the systemic therapy component that defines the standard of care.

What to do instead

For any high-risk pathologic feature (positive margin, extranodal extension), state the triplet explicitly: postoperative RT plus concurrent platinum, then cite the indication for adding it.

Mistake 4

Selecting chemotherapy or radiation dose modifications for a patient with head and neck cancer without first confirming renal function, hearing status, and performance status that determine cisplatin eligibility.

Cisplatin is the default radiosensitizer in candidates' minds, and the eligibility workup is treated as a formality rather than a decision-driving step.

What to do instead

Before choosing a systemic agent, list the three gating variables (creatinine clearance, audiogram/baseline hearing, ECOG status) and state the alternative (e.g., cetuximab or carboplatin/5-FU) if any gate fails.

Mistake 5

Describing the blood supply, lymphatic drainage, or nerve relationships of a head and neck subsite in general terms without naming the specific named vessel, nerve, or nodal level relevant to the tumor being discussed.

Anatomy is studied regionally rather than by surgical relevance, so candidates can name structures but cannot map them onto the operative field or drainage pathway for a given primary.

What to do instead

For each major subsite, rehearse a three-item template: dominant arterial supply, at-risk named nerve, and first-echelon nodal levels; apply the template to the specific case rather than reciting general anatomy.

Mistake 6

Planning rehabilitation and supportive care only after treatment completion rather than building pre-treatment baseline assessment (speech, swallowing, dental, nutrition, shoulder function) into the initial plan.

Candidates associate rehabilitation with survivorship and view it as downstream of oncologic treatment, missing the prehabilitation and prophylactic components that change outcomes.

What to do instead

For every curative-intent plan, add a pre-treatment baseline block covering swallow evaluation, dental assessment before radiation, nutrition status, and shoulder/PT assessment, and state what is prophylactic versus reactive.

Mistake 7

Answering quality, safety, or practice-management items by citing a general patient-safety principle instead of the specific head and neck–relevant process measure, such as tracking margin status, nodal yield, or time from surgery to adjuvant radiation.

These domains feel like generic professionalism content, so candidates answer with broad concepts and fail to connect them to measurable head and neck metrics.

What to do instead

Memorize a short list of concrete head and neck quality metrics (margin rate, lymph node yield, adjuvant RT interval, tracheostomy care bundle, unplanned readmission) and answer with the metric plus the process it audits.

Mistake 8

When a research or ethics item presents a conflict of interest, informed consent nuance, or equipoise question, answering with the clinically 'best' option rather than the ethically or methodologically correct one.

Candidates default to clinical reasoning under time pressure and treat ethics and research design as soft content that does not require the same rule-based analysis.

What to do instead

For ethics and research items, first identify which principle or design element is being tested (autonomy, equipoise, allocation concealment, conflict disclosure), then answer to that element before considering clinical preference.

Mistake 9

Assigning an overall stage group from the AJCC manual without checking whether the edition in use applies a different staging system for the relevant subsite (e.g., HPV-mediated oropharyngeal cancer or EBV-associated nasopharyngeal cancer).

Candidates memorize one stage-group table and apply it uniformly, overlooking that certain subsites have separate staging schemas and that edition changes alter group definitions.

What to do instead

Before computing a stage group, confirm the subsite-specific schema and edition, and state the schema name (e.g., HPV-mediated p16-positive oropharyngeal) alongside the T, N, and M that feed it.

Mistake 10

Recommending a treatment modality for a resectable head and neck cancer without explicitly weighing organ preservation, functional outcome, and patient preference against survival equivalence before committing to surgery or chemoradiation.

Candidates anchor on oncologic control and treat multidisciplinary planning as choosing the 'most definitive' option, skipping the functional and preference comparison that defines true multidisciplinary care.

What to do instead

For each curative case, produce a two-column comparison of surgery versus organ-preserving therapy listing survival, functional impact, and patient factors, and state the deciding factor explicitly.